ARTICLE | Clinical News
Nuwiq simoctogog alfa regulatory update
November 24, 2014 8:00 AM UTC
Health Canada approved Octaphama’s Nuwiq recombinant FVIII ( rFVIII) to treat and prevent bleeding in patients with hemophilia A. The rFVIII concentrate produced in a genetically modified human embry...